Niklas Berglind

AstraZeneca R&D
Moelndal, O, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Effects of zibotentan and dapagliflozin combined in patients with compensated cirrhosis: A randomized placebo-controlled exploratory study.

Effects of zibotentan and dapagliflozin combined in patients with compensated cirrhosis: A randomized placebo-controlled exploratory study.

Journal: British journal of clinical pharmacology

Published: March 26, 2025

Infection rates in patients from five rheumatoid arthritis (RA) registries: contextualising an RA clinical trial programme.

Infection rates in patients from five rheumatoid arthritis (RA) registries: contextualising an RA clinical trial programme.

Journal: RMD open

Published: May 13, 2017

Association of faecal elastase 1 with non-fasting triglycerides in type 2 diabetes.

Association of faecal elastase 1 with non-fasting triglycerides in type 2 diabetes.

Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]

Published: November 30, 2015

Can rheumatoid arthritis (RA) registries provide contextual safety data for modern RA clinical trials? The case for mortality and cardiovascular disease.

Can rheumatoid arthritis (RA) registries provide contextual safety data for modern RA clinical trials? The case for mortality and cardiovascular disease.

Journal: Annals of the rheumatic diseases

Published: October 01, 2015

How comparable are rates of malignancies in patients with rheumatoid arthritis across the world? A comparison of cancer rates, and means to optimise their comparability, in five RA registries.

How comparable are rates of malignancies in patients with rheumatoid arthritis across the world? A comparison of cancer rates, and means to optimise their comparability, in five RA registries.

Journal: Annals of the rheumatic diseases

Published: June 20, 2015

Inverse association of HbA1c with faecal elastase 1 in people without diabetes.

Inverse association of HbA1c with faecal elastase 1 in people without diabetes.

Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]

Published: January 27, 2015

Using epidemiological registry data to provide background rates as context for adverse events in a rheumatoid arthritis drug development program: a coordinated approach.

Using epidemiological registry data to provide background rates as context for adverse events in a rheumatoid arthritis drug development program: a coordinated approach.

Journal: Pharmacoepidemiology and drug safety

Published: January 16, 2015

Methodological Challenges When Comparing Demographic and Clinical Characteristics of International Observational Registries.

Methodological Challenges When Comparing Demographic and Clinical Characteristics of International Observational Registries.

Journal: Arthritis care & research

Published: January 06, 2015

Long-term 4-year safety of saxagliptin in drug-naive and metformin-treated patients with Type 2 diabetes.

Long-term 4-year safety of saxagliptin in drug-naive and metformin-treated patients with Type 2 diabetes.

Journal: Diabetic medicine : a journal of the British Diabetic Association

Published: November 21, 2012

The efficacy and safety of the dipeptidyl peptidase-4 inhibitor saxagliptin in treatment-naïve patients with type 2 diabetes mellitus: a randomized controlled trial.

The efficacy and safety of the dipeptidyl peptidase-4 inhibitor saxagliptin in treatment-naïve patients with type 2 diabetes mellitus: a randomized controlled trial.

Journal: Diabetology & metabolic syndrome

Published: February 24, 2012

Showing 1-10 of 10

Last Updated: 09/26/2026